【摘要】 目的 探討機采血小板在實驗室內保存期間的生化改變及其意義。 方法 采用ROCHE cobas b 221和OLYMPUS AU400測定血小板樣本的pH值、PO2、PCO2、葡萄糖（GLU）濃度、乳酸脫氫酶（LDH）釋放量。 結果 保存期間pH值由7.311（第1天）降至7.116（第5天）；PO2波動于106.7～119.5 mm Hg（1 mm Hg=0.133 kPa）；PCO2波動于25.0～35.8 mm Hg；GLU濃度呈進行性下降，由18.8 mmol/L降至15.2 mmol/L；LDH濃度顯著增加，由150 mmol/L（第1天）增至259 mmol/L（第5天）。 結論 血小板在保存期內，其生化參數會隨著保存時間發生改變。而這些參數作為間接指標對機采血小板是否被細菌污染具有一定的指導意義。【Abstract】 Objective To observe the biochemistry changes of apheresis platelets (AP), including pH, PO2, PCO2, GLU, LDH, within the storage time and its significance. Methods The pH, PO2, PCO2, GLU and LDH of platelet samples were detected by ROCHE cobas b 221 and OLYMPUS AU400. Results During the storage time, the pH value of platelet decreased gradually from 7.311 (the first day) to 7.116 (the fifth day); the PO2 fluctuated from 106.7 mm Hg (1 mm Hg=0.133 kPa) to 119.5 mm Hg; the PCO2 fluctuated from 25.0 mm Hg to 35.8 mm Hg;the concentration of GLU decreased from 18.8 mmol/L to 15.2 mmol/L;the concentration of LDH increased observably from 150 mmol/L (the first day) to 259 mmol/L (the fifth day). Conclusion There were observably changes of biochemistry of the AP during storage time, and these changes may be the indicators of platelets contamination.
Objective To introduce the application of platelet-rich plasma (PRP) in non-vascularised bone grafts (NVBG) of maxillofacial surgery and its potential mechanism in recent years.Methods The latest articles were extensively retrieved, and the potential mechanism for PRP promotes the osteogenesis was discussed. Results PRP promotes osteogenesis when applied to NVBG, and the cytokine included in platelet is thought to be the ingredient for PRP’s effect. Some scholar has already applied PRP in the restoration of maxillofacial bone defect andgot good results. Conclusion PRP has the potential to promotesosteogenesis, and more studies are needed for further understanding of its mechanism.
【摘要】 目的 評價重組人血小板生成素（rhTPO）治療腫瘤化療后血小板減少的療效和安全性。 方法 2008年12月-2009年10月收住惡性腫瘤患者45例，在化療后出現血小板減少，隨機分為A、B組，A組皮下注射rhTPO（15 000 U/d），B組皮下注射白細胞介素-11（1.5 mg/d），動態監測注射后血小板生長情況。 結果 A組血小板計數的最低值明顯高于B組（Plt;0.05）；A組血小板開始恢復時間較B組明顯縮短（Plt;0.01）；血小板恢復至100×109/L以上所需時間A組較B組明顯縮短（Plt;0.05），分別為（6.18±4.20）和（10.46±4.54） d，血小板恢復的最高值兩組差異無統計學意義（Pgt;0.05）；B組有2例患者化療后需要輸入外源性血小板，A組無患者需要輸入血小板；與B組比較，A組較少發生不良反應，患者可以耐受。 結論 重組人血小板生成素是一種治療化療后出現血小板減少的有效方法。【Abstract】 Objective To evaluate the therapeutic effect of recombinant human thrombopoietin (rhTPO) on chemotherapy-induced thrombocytopenia. Methods Forty-five in-patients with malignant tumor from December 2008 to October 2009 who had thrombocytopenia after chemotherapy were randomly divided into A and B groups. The patients in group A underwent the hypodermic injection with rhTPO (15 000 U/d) while in group B with interleukin-11 (1.5 mg/d);the platelet count was checked consecutively. Results Compared with that in group B, the platelet count was obviously higher (Plt;0.01) and the time of declined platelet count beginning to recover was significantly shorter in group A. The time of platelet count increasing to 100×109/L was within (6.18±4.20) days in group B which was significantly shorter than (10.46±4.54) days in group B (Plt;0.05). However, no significant was found between the two groups in the maximal platelet count (Pgt;0.05). Two patients needed platelet transfusion in group B and no one did in group A. Conclusion rhTPO is safe and effective for chemotherapy-induced thrombocytopenia.
ObjectiveTo prepare platelet-derived growth factor receptor β (PDGFRβ)-targeted near-infrared molecular probe and evaluate its potential in optical molecular imaging of lung cancer.MethodsPDGFRβ-specific affibody Z-tri was recombinantly expressed in Escherichia coli (E. coli) and purified using affinity chromatography. In vitro cell-binding of Z-tri was analyzed by flow cytometry. Cellular distribution of Z-tri in tumor grafts was determined by protein-tracing. The molecular probe CF750-Z-tri was prepared by conjugating near-infrared fluorescent dye CF750 to Z-tri. The optical images of xenografts of lung cancer were obtained by using CF750-Z-tri combined with optical imaging system.ResultsPDGFRβ-specific affibody Z-tri was highly expressed in E. coli and purified to homogeneity. Z-tri could bind PDGFRβ-positive cells but not PDGFRβ-negative cells cultured in vitro. In the tumor xenografts of human lung cancer, intravenously injected Z-tri was predominantly distributed on cells overexpressing PDGFRβ. The near infrared fluorescent dye CF750 was efficiently conjugated to Z-tri. Optical images with high contrast of lung cancer xenografts were produced by using the near-infrared fluorescent probe CF750-Z-tri combined with optical imaging system.ConclusionThe near-infrared fluorescent probe CF750-Z-tri can be used for optical imaging of human lung cancer, which takes great potential in optical imaging-guided surgery of lung cancer.
Objective To investigate the relationship between thrombocytopenia after the restoration of spontaneous circulation and short-term prognosis of patients with in-hospital cardiac arrest. Methods The demographic data, post-resuscitation vital signs, post-resuscitation laboratory tests, and the 28-day mortality rate of patients who experienced in-hospital cardiac arrest at the Emergency Department of West China Hospital, Sichuan University between January 1st, 2016 and December 31st, 2016 were retrospectively analyzed. Logistic regression was used to analyze the correlation between thrombocytopenia after the return of spontaneous circulation and the 28-day mortality rate in these cardiac arrest patients. Results Among the 285 patients included, compared with the normal platelet group (n=130), the thrombocytopenia group (n=155) showed statistically significant differences in red blood cell count, hematocrit, white blood cell count, prothrombin time, activated partial thromboplastin time, and international normalized ratio (P<0.05). The 28-day mortality rate was higher in the thrombocytopenia group than that in the normal platelet group (84.5% vs. 71.5%, P=0.008). Multiple logistic regression analysis indicated that thrombocytopenia [odds ratio =2.260, 95% confidence interval (1.153, 4.429), P=0.018] and cardiopulmonary resuscitation duration [odds ratio=1.117, 95% confidence interval (1.060, 1.177), P<0.001] were independent risk factors for 28-day mortality in patients with in-hospital cardiac arrest. Conclusion Thrombocytopenia after restoration of spontaneous circulation is associated with poor short-term prognosis in patients with in-hospital cardiac arrest.
Objective
To investigate the effects of autologous platelet-rich gel (APG) combined with intelligent trauma negative-pressure comprehensive therapeutic instrument on patients with refractory diabetic foot ulcer (DFU).
Methods
A total of 80 patients with refractory DFU treated in the hospital from January 2015 to January 2017 were divided into the trial group (n=40) and the control group (n=40) by the random number table method. The patients in the two groups were given routine treatment, and on the basis, the patients in the control group were treated with the intelligent trauma negative-pressure comprehensive therapeutic instrument while the ones in the trial group were treated with APG combined with intelligent trauma negative-pressure therapeutic instrument alternately. All patients were observed for 12 weeks. The cure rates, healing time and changes of wound volumes in the two groups before treatment and at 2, 4, 8, and 12 weeks after treatment were recorded.
Results
The total effective rate of treatment in the trial group was higher than that in the control group (87.5% vs. 67.5%, P<0.05). The wound volumes in the two groups at 4, 8 and 12 weeks after treatment were smaller than those before treatment and at 2 weeks after treatment (P<0.05). The wound volumes in the trial group at 4, 8 and 12 weeks after treatment were significantly smaller than those in the control group (P<0.05). The healing times of Wagner Ⅱ and Ⅲ DFU in the trial group were significantly shorter than those in the control group [(24.71±4.29)vs. (33.84±6.09) days, P<0.05; (33.04±5.97)vs. (45.29±7.05) days, P<0.05].
Conclusion
Alternate treatment with APG combined with intelligent trauma negative-pressure comprehensive therapeutic instrument for refractory DFU can promote wound healing, shorten wound healing time, and improve the clinical efficacy.
